Reference : Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
Patent : Patent
Life sciences : Biochemistry, biophysics & molecular biology
http://hdl.handle.net/2268/62853
Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
English
Weiner, Richard I. [ > > ]
Martial, Joseph mailto [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >]
Struman, Ingrid mailto [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >]
Taylor, Robert [ > > ]
Bentzien, Frauke [ > > ]
17-Apr-2008
2007-10-19
United States
US 2008/0090750 A1
11/875,308
B
United States
Weiner R., Martial J., Struman I., Taylor R., Bentzien F.
A61K 38/00, A61P 43/00, C07K 16/00
U.S. Cl. 514/2, 530/300
US
EP
[en] Antiangiogenic ; Peptide
[en] The current invention concerns novel antiangiogenic peptides which correspond to about 10 to about 150 consecutive amino acids of N-terminal sequences of human growth hormones, human placental lactogen, human growth hormone variant hGH-V, and prolactin, and their use in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormalities of placental vascularization.
Giga-Cancer
http://hdl.handle.net/2268/62853

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.